Related Experiment Video
Updated: Apr 17, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
High-Risk CCL14 lineage drives severe Mycoplasma pneumoniae pneumonia in children: a study in central China
Chunbo Hao1, Zijie Li1, Yanjuan Yu1
1Henan International Joint Laboratory of Children's Infectious Diseases, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, China.
Background:
The post-coronavirus disease 2019 (COVID-19) pandemic resurgence of Mycoplasma pneumoniae (MP) infections, particularly in China, underscores the need to understand the drivers of disease severity.
Purpose:
This study aimed to evaluate the association between predominantly circulating MP strains and disease severity in Henan Province, central China.
Methods:
We integrated the clinical data of 3,060 pediatric patients and analyzed the epidemiological characteristics of MP pneumonia (MPP) in the Henan region in 2020-2024. Bronchoalveolar lavage fluid collected from 137 patients was analyzed using multilocus sequence typing and multilocus variable number tandem-repeat analysis to investigate the correlation between genotype and clinical outcome.
Results:
A significant post-COVID MPP outbreak was predicted in 2023. Genotyping revealed the cocirculation of 2 major genotypes: the prevalent ST3 (57.7%, severe ratio [31.6%]) and the less common but highly virulent ST14 (26.3%, severe ratio [72.2%]). Phylogenetic clustering confirmed ST14/3-5-6-2 as part of a broader hypervirulent lineage, common cluster label 14 (CCL14), which was significantly associated with disease severity (χ2=19.39; P<0.001). Patients infected with CCL14 strains exhibited a distinct hyperinflammatory profile marked by elevated D-dimer levels, complement C4 levels, and platelet count. The mutation ratio of macrolide resistance sites in the MP strains from Henan Province was approximately 75%.
Conclusion:
Our findings identified the CCL14 lineage as a key driver of disease severity in macrolide-resistant pediatric MPP in Henan Province, China. This under scores the importance of integrating molecular surveillance with clinical monitoring to mitigate disease burden.
Insights
A hypervirulent Mycoplasma pneumoniae (MP) strain, CCL14, drove severe pediatric pneumonia post-COVID in China. This macrolide-resistant strain necessitates integrated surveillance for better disease management.
Area of Science:
- Infectious Diseases
- Molecular Epidemiology
- Pediatric Pneumology
Background:
- Post-pandemic Mycoplasma pneumoniae (MP) infections surged, especially in China.
- Understanding MP strain genetics and severity links is crucial but lacking for central China.
- Genotypic characterization of prevalent MP strains and their clinical impact requires further investigation.
Purpose of the Study:
- To assess the association between predominant MP strains and disease severity.
- To analyze epidemiological features of MP pneumonia (MPP) in Henan, China (2020-2024).
- To correlate MP genotypes with clinical outcomes in pediatric patients.
Main Methods:
- Integrated clinical data from 3,060 pediatric patients.
- Epidemiological analysis of MPP in Henan region.
- Multilocus sequence typing (MLST) and MLVA on bronchoalveolar lavage fluid (BALF) from 137 patients.
- Phylogenetic analysis to identify strain lineages.
Main Results:
- Two major MP genotypes co-circulated: ST3 (57.7%, 31.6% severe) and ST14 (26.3%, 72.2% severe).
- The ST14/3-5-6-2 lineage (CCL14) was significantly linked to increased disease severity (P<0.001).
- CCL14-infected patients showed hyperinflammation (elevated D-dimer, C4, platelets); ~75% of strains were macrolide-resistant.
Conclusions:
- The CCL14 lineage drives severe, macrolide-resistant pediatric MPP in Henan, China.
- Molecular surveillance integrated with clinical monitoring is vital for reducing disease burden.
- Identifying hypervirulent MP strains is key to managing outbreaks.
Related Concept Videos
Atypical Pneumonia
Pneumonia II: Pathophysiology
Bacterial Phylum Chlamydiae
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Cytomegalovirus Disease
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation